NERVGEN PHARMA CORP. Adjustments For Interest Income
NERVGEN PHARMA CORP. (NGEN) reported Adjustments For Interest Income of CAD 3.69 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForInterestIncome · last filed 2026-03-31
| Period end | Adjustments For Interest Income 12 month |
|---|---|
| 2025-12-31 | 3.69K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 6.37K CAD 40-F · filed 2026-03-31 |